{"id":"W4410349213","doi":"10.1016/j.lungcan.2025.108583","title":"Real-world survival outcomes, treatment patterns, and impact of PD-L1 expression among patients with unresectable, stage III NSCLC treated with CRT → durvalumab in Canada: The RELEVANCE study","year":2025,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"Public Health Ontario; AstraZeneca (Canada); Institut universitaire de cardiologie et de pneumologie de Québec; Dalhousie University; Université Laval; Queen Elizabeth II Health Sciences Centre; Université de Montréal; University of Calgary; Centre Hospitalier de l’Université de Montréal; BC Cancer Agency; Ottawa Hospital","funders":"AstraZeneca","keywords":"Durvalumab; Medicine; Stage (stratigraphy); Oncology; Internal medicine; Overall survival; Relevance (law); Cancer; Immunotherapy; Nivolumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001245892,0.0002762005,0.0005637563,0.000121036,0.00008299531,0.00001611952,0.00009999404,0.00003362347,0.00009761658],"category_scores_gemma":[0.000007369425,0.0001317496,0.00005043092,0.0004978275,0.00007188913,0.00007745242,0.00002951495,0.0001332447,3.269417e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00285734,"about_ca_system_score_gemma":0.001460579,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.988673,"about_ca_topic_score_gemma":0.9918272,"domain_scores_codex":[0.9985059,0.0001121845,0.0003280877,0.0003447804,0.0004107754,0.0002982142],"domain_scores_gemma":[0.9990933,0.000129281,0.0001775286,0.0004390495,0.00009426596,0.00006658649],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01281249,0.0003486591,0.9823052,0.0000757433,0.0008575045,0.00002860864,0.0004252792,0.00009941343,0.00009484534,6.62494e-7,0.0002054566,0.002746179],"study_design_scores_gemma":[0.01768811,0.0009878989,0.9788708,0.0008957094,0.0002121552,2.484331e-7,0.0005631728,0.00006779981,0.0005001295,1.494282e-7,0.00007006136,0.0001437731],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968266,0.0005026938,0.000004082051,0.00009867973,0.00008843139,0.001778213,0.0001558908,0.00001471727,0.0005307294],"genre_scores_gemma":[0.995334,0.0004524716,0.000005130778,0.0000510552,0.00001229869,0.0002169644,0.00002877178,0.00002520989,0.003874134],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004875628,"threshold_uncertainty_score":0.7471843,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008585620769715262,"score_gpt":0.2952468966671313,"score_spread":0.286661275897416,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}